Wellington Management Group
ALXN

Wellington Management Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Wellington Management Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-44,922
Closed -$8.25M – 2353
2021
Q2 		$8.25M Sell
44,922
-4,437
-9% -$762K ﹤0.01% 1343
2021
Q1 		$7.55M Sell
49,359
-136,162
-73% -$21.1M ﹤0.01% 1313
2020
Q4 		$29M Buy
185,521
+159,442
+611% +$20.5M 0.01% 949
2020
Q3 		$2.98M Buy
26,079
+13,135
+101% +$1.42M ﹤0.01% 1356
2020
Q2 		$1.45M Sell
12,944
-1,133
-8% -$120K ﹤0.01% 1412
2020
Q1 		$1.26M Sell
14,077
-5,470
-28% -$537K ﹤0.01% 1466
2019
Q4 		$2.11M Buy
19,547
+2,496
+15% +$267K ﹤0.01% 1537
2019
Q3 		$1.67M Sell
17,051
-2,865
-14% -$323K ﹤0.01% 1629
2019
Q2 		$2.61M Buy
19,916
+7,252
+57% +$935K ﹤0.01% 1549
2019
Q1 		$1.71M Sell
12,664
-584
-4% -$72.6K ﹤0.01% 1656
2018
Q4 		$1.29M Buy
13,248
+130
+1% +$15.4K ﹤0.01% 1747
2018
Q3 		$1.82M Sell
13,118
-8,414
-39% -$1.06M ﹤0.01% 1727
2018
Q2 		$2.67M Buy
21,532
+6,881
+47% +$804K ﹤0.01% 1656
2018
Q1 		$1.63M Buy
+14,651
New +$1.75M ﹤0.01% 1789
2017
Q4 		– Sell
-2,314
Closed -$325K – 2335
2017
Q3 		$325K Buy
+2,314
New +$314K ﹤0.01% 2117
2015
Q3 		– Sell
-1,115
Closed -$202K – 2275
2015
Q2 		$202K Sell
1,115
-45,668
-98% -$7.88M ﹤0.01% 2104
2015
Q1 		$8.11M Sell
46,783
-112,304
-71% -$20.3M ﹤0.01% 1303
2014
Q4 		$29.4M Buy
159,087
+109,163
+219% +$20.2M 0.01% 916
2014
Q3 		$8.28M Buy
49,924
+1,827
+4% +$300K ﹤0.01% 1297
2014
Q2 		$7.51M Buy
48,097
+1,892
+4% +$299K ﹤0.01% 1333
2014
Q1 		$7.03M Buy
+46,205
New +$7.35M ﹤0.01% 1343
2013
Q4 		– Sell
-30,635
Closed -$3.56M – 2249
2013
Q3 		$3.56M Buy
+30,635
New +$3.36M ﹤0.01% 1513

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Wellington Management Group's ALXN Position: Q3 2021 in Review

Wellington Management Group sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 44,922 shares — an estimated $8.25M sold.

Wellington Management Group first reported a position in ALXN in Q3 2013 and held it in 22 quarters. The position peaked at $29.4M in Q4 2014. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Wellington Management Group reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Wellington Management Group sold 44,922 Alexion Pharmaceuticals shares in Q3 2021, an estimated $8.25M.
  • Wellington Management Group first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 22 quarters.
  • Wellington Management Group's Alexion Pharmaceuticals position peaked at $29.4M in Q4 2014.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Wellington Management Group's 13F filing for Q3 2021, filed 15 Nov 2021.